文献速递脑血管病外科神经重症

脑室腰大池冲洗对动脉瘤性蛛网膜下腔出血后迟发性脑梗死及结局的影响:一项前瞻性登记研究

Ventriculolumbar Irrigation Effects on Delayed Cerebral Infarction and Outcome After Aneurysmal Subarachnoid Hemorrhage: A Prospective Registry Study.
PubMed 文献 · Neurosurgery · 2026-10-12

该前瞻性登记研究比较了基于脑室腰大池冲洗(VLI)的ABCD疗法与标准治疗在动脉瘤性蛛网膜下腔出血(aSAH)患者中的效果。结果显示VLI组迟发性脑梗死(DCI)发生率、mRS评分及分流依赖性脑积水均显著低于匹配对照组。结论认为VLI是一种床旁可用的简化技术,可改善结局,但需随机试验证实。

要点

  • VLI组DCI发生率为9.7%,显著低于对照组的29.9%(P < .001)。
  • VLI组平均mRS为2.33,显著低于对照组的3.37(P < .001)。
  • VLI组分流依赖性脑积水发生率为9.7%,显著低于对照组的31.9%(P < .001)。

核心结论

  • 基于VLI的ABCD疗法与更低的DCI发生率、更好的180天mRS结局及更低的分流依赖性脑积水相关。
  • VLI是一种床旁可用的简化技术,可主动清除鞘内血液并局部给予解痉治疗以预防DCI。
  • 需随机试验确认这些发现。

研究设计与样本

  • 前瞻性登记研究,纳入2019至2025年连续接受新型VLI-based ABCD疗法(压力控制VLI联合尿激酶及按需尼莫地平)的aSAH患者。
  • 与接受标准治疗的匹配对照组进行比较。
  • 主要结局为DCI发生率,次要结局为180天改良Rankin量表(mRS)。

主要发现

  • VLI组DCI发生率为9.7%,对照组为29.9%(P < .001)。
  • VLI组平均mRS为2.33,对照组为3.37(P < .001)。
  • VLI组分流依赖性脑积水发生率为9.7%,对照组为31.9%(P < .001)。
  • 与单纯被动脑脊液引流相比,VLI组DCI发生率更低(9.7% vs 30.7%,P < .001),平均mRS更低(2.33 vs 3.39,P < .001)。

临床怎么用

  • VLI可作为床旁技术用于aSAH后主动清除鞘内血液并局部解痉以预防DCI。
  • 该疗法与更低的DCI、分流依赖性脑积水及更好的180天功能结局相关。

局限性

  • 为前瞻性登记研究而非随机对照试验,需随机试验确认发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Aneurysmal subarachnoid hemorrhage (aSAH) remains associated with high morbidity and mortality, largely determined by delayed cerebral ischemia (DCI). Active blood clearance and vasodilation (ABCD) therapy targets key pathophysiological mechanisms of DCI by enhancing the clearance of blood from cerebrospinal fluid and counteracts vasospasm through continuous intrathecal fibrinolytic and spasmolytic irrigation. Although ABCD therapy has previously been implemented using technically demanding treatment approaches, this study introduces ventriculolumbar irrigation (VLI) as a simplified, bedside-applicable method. This study evaluates whether VLI-based ABCD therapy is associated with an improvement in DCI and morbidity. METHODS: In this prospective registry study, consecutive aSAH patients treated with the novel VLI-based ABCD therapy (pressure-controlled VLI with urokinase and on-demand nimodipine) between 2019 and 2025 were compared with matched controls receiving standard care. The primary outcome was the incidence of DCI and the secondary outcome was modified Rankin Scale (mRS) at 180 days. RESULTS: Seventy-two patients treated with VLI-based ABCD therapy were compared with 144 matched controls. VLI treatment was associated with significantly lower rates of DCI (9.7% vs 29.9%, P < .001), morbidity (mean mRS 2.33 vs 3.37, P < .001), and shunt-dependent hydrocephalus (9.7% vs 31.9%, P < .001). Compared with isolated, passive cerebrospinal fluid drainage, VLI was associated with lower DCI rates (9.7% vs 30.7%, P < .001) and reduced morbidity (mean mRS 2.33 vs 3.39, P < .001). CONCLUSION: The novel and simplified VLI therapy was associated with considerably improved outcomes: lower DCI rates and shunt-dependent hydrocephalus. VLI offers a bedside technique to actively remove intrathecal blood and deliver intrathecal spasmolysis for the prevention of DCI. Randomized trials are needed to confirm these findings.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Overstijns M, Scheiwe C, El Rahal A, et al. Ventriculolumbar Irrigation Effects on Delayed Cerebral Infarction and Outcome After Aneurysmal Subarachnoid Hemorrhage: A Prospective Registry Study. Neurosurgery. 2026. PMID: 42861997. doi:10.1227/neu.0000000000004260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。